Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $363,478 - $431,330
-9,035 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$38.79 - $43.16 $34,911 - $38,844
-900 Reduced 9.06%
9,035 $346,000
Q2 2021

Aug 16, 2021

SELL
$36.52 - $41.46 $351,870 - $399,467
-9,635 Reduced 49.23%
9,935 $395,000
Q1 2021

May 17, 2021

BUY
$34.27 - $40.01 $325,976 - $380,575
9,512 Added 94.57%
19,570 $699,000
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $140,232 - $164,393
-4,116 Reduced 29.04%
10,058 $370,000
Q3 2020

Nov 16, 2020

SELL
$38.11 - $42.99 $54,687 - $61,690
-1,435 Reduced 9.19%
14,174 $534,000
Q2 2020

Aug 14, 2020

SELL
$37.87 - $43.58 $126,031 - $145,034
-3,328 Reduced 17.57%
15,609 $637,000
Q1 2020

May 15, 2020

SELL
$32.47 - $48.83 $57,082 - $85,843
-1,758 Reduced 8.49%
18,937 $717,000
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $16,758 - $19,251
-399 Reduced 1.89%
20,695 $973,000
Q3 2019

Nov 14, 2019

BUY
$40.46 - $43.52 $81,122 - $87,257
2,005 Added 10.5%
21,094 $900,000
Q2 2019

Aug 14, 2019

BUY
$39.4 - $42.7 $51,771 - $56,107
1,314 Added 7.39%
19,089 $764,000
Q1 2019

May 15, 2019

SELL
$38.57 - $42.69 $35,522 - $39,317
-921 Reduced 4.93%
17,775 $742,000
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $306,671 - $346,343
-8,113 Reduced 30.26%
18,696 $715,000
Q3 2018

Nov 14, 2018

SELL
$39.75 - $42.69 $85,462 - $91,783
-2,150 Reduced 7.42%
26,809 $1.08 Million
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $43,174 - $46,608
1,090 Added 3.91%
28,959 $1.17 Million
Q1 2018

May 15, 2018

SELL
$36.18 - $40.15 $1.63 Million - $1.81 Million
-45,066 Reduced 61.79%
27,869 $1.09 Million
Q4 2017

Feb 14, 2018

BUY
$35.34 - $41.9 $180,587 - $214,109
5,110 Added 7.53%
72,935 $2.59 Million
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $2.68 Million - $2.82 Million
67,825
67,825 $2.75 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.